Tirzepatide to Reduce rEcurrence And Burden After Ablation of Atrial Fibrillation
Clinical trial NCT07382024 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07382024
- Sponsor
- National Taiwan University Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-16
- Primary completion
- 2027-12-31
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.